Overview
- Editors:
-
-
Xingshun Qi
-
Department of Gastroenterology, General Hospital of Northern Theater Command, Shenyang, China
-
Yongping Yang
-
Faculty of Liver Disease of Chinese People’s Liberation Army General Hospital, The Fifth Medical Center of the Chinese People’s Liberation Army General Hospital, Beijing, China
- Presents current and emerging pharmacotherapy for management of liver cirrhosis comprehensively
- Introduces indications and contra-indications of different types of drug in management of liver cirrhosis
- Supported by authoritative sources and published clinical trials
Access this book
Other ways to access
Table of contents (14 chapters)
-
-
-
- Yunyu Zhao, Xinyuan He, Fanpu Ji
Pages 11-22
-
- Feng Su, Patrick G. Northup
Pages 23-48
-
- Swati Chouhan, Prajna Anirvan, Shivaram Prasad Singh
Pages 49-67
-
-
- Wenkang Gao, Zhonglin Li, Huikuan Chu, Hang Yuan, Lilin Hu, Lin Yao et al.
Pages 81-111
-
- Zhaohui Bai, Meijuan Zou, Xiaoying Zhang, Gang Cheng
Pages 113-125
-
- Mathias Jachs, Thomas Reiberger
Pages 127-140
-
-
- Florence Wong, Tilman Sauerbruch
Pages 149-166
-
- Ran Wang, Lu Chai, Xiaozhong Guo
Pages 167-178
-
- Alberto E. Muñoz, Mariano Cartier, Ayelén B. Kisch
Pages 179-204
-
-
- Jessica Faccioli, Stefania Gioia, Silvia Nardelli, Oliviero Riggio, Lorenzo Ridola
Pages 223-240
About this book
This book aims to provide an updated information on different types of major and emerging drugs for managing liver cirrhosis and its complications, including acute gastroesophageal variceal bleeding, ascites, hepatic encephalopathy, liver failure, acute kidney injury, and portal venous thrombosis. The chapters are organized by drug class, such as anti-HBV drugs, anti-HCV drugs, anticoagulants, and antibiotics, etc. The clinical efficacy, indication, and contra-indication of the various drug therapies are discussed using supportive reference material from authoritative sources and published clinical trials. It will be an invaluable reference for physicians who are treating patients with liver cirrhosis, especially those presenting with acute life-threatening complications.
Editors and Affiliations
-
Department of Gastroenterology, General Hospital of Northern Theater Command, Shenyang, China
Xingshun Qi
-
Faculty of Liver Disease of Chinese People’s Liberation Army General Hospital, The Fifth Medical Center of the Chinese People’s Liberation Army General Hospital, Beijing, China
Yongping Yang
About the editors
Xingshun Qi is an Associate Professor at the Department of Gastroenterology, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.Yongping Yang is a Professor at Department of Liver Disease, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
